Laurus Labs latest update leaves the fair value estimate at roughly ₹821.93 per share with a steady discount rate of 12.76%, underscoring that the market narrative is shifting more on expectations ...

Hyderabad: Laurus Bio, a subsidiary of Hyderabad-based biopharma player Laurus Labs Ltd, has secured an equity investment of Rs 120 crore from Eight Roads Ventures and F-Prime Capital. Laurus Labs ...

Laurus Labs API segment is also well set to clock strong growth backed by the company’s increasing focus to diversify into new therapy areas - anti-diabetes and cardiology along with an eye to gain a ...

PetroAlgae, a Melbourne, Fla., company, is a renewable energy miracle--at least in the stock market. The company, which aims to harvest oil from algae, started trading on the OTC Bulletin Board in ...

An analyst from Master Capital Services said that Bank of India has taken strong support at its long-term horizontal support ...

Revenue: INR1,570 crores, reflecting a 31% year-on-year growth. Gross Margin: 59%, an increase of more than 4% due to better product mix and process improvements. EBITDA: INR389 crores with a margin ...

US drug-development services company Aptuit has cemented its commitment to the Indian market by entering into a joint venture with Hyderabad-based Laura Labs. US drug-development services company ...

Laurus Labs rallies to 52-week high after strong Q1, but analysts remain cautious with downside risk of up to 33 per cent. Laurus Labs has gained 18.36 per cent in the past month. Shares of Laurus ...

Last night, after midnight, I read the last lines of Laurus, a newly translated Russian novel by Eugene Vodolazkin, and thought it surely must be the most perfect ending ever. There is no way it could ...

A number of you got the new Evgeny Vodolazkin novel Laurus for Christmas, and have been writing to tell me how great it is. Justin Ryan Lonas wrote a rave review calling the novel a “revelation.” The ...